Logotype for Scandinavian ChemoTech

Scandinavian ChemoTech (CMOTEC) investor relations material

Scandinavian ChemoTech Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Scandinavian ChemoTech
Q3 2025 earnings summary4 Nov, 2025

Executive summary

  • Q3 2025 saw continued strong momentum, with Animal Care division sales nearly matching the previous quarter's record and total revenue for the first nine months surpassing the entire previous year.

  • The U.S. market is the primary growth driver, with rapid adoption of vetlQure systems; Europe is also growing steadily.

  • Animal Care surpassed 3,000 treatments performed worldwide, highlighting the impact and acceptance of TSE technology.

  • Recruitment for specialized sales roles remains challenging, but the marketing team was expanded to support growth.

  • R&D investments continue, focusing on software and advanced treatment kits to maintain technological leadership.

Financial highlights

  • Q3 net sales: 3,324 KSEK (up from 1,499 KSEK year-over-year); nine-month net sales: 9,637 KSEK (up from 4,525 KSEK year-over-year).

  • Q3 net loss: -1,267 KSEK (improved from -3,243 KSEK year-over-year); nine-month net loss: -5,532 KSEK (improved from -10,550 KSEK year-over-year).

  • Cash flow from operating activities for Q3: -1,663 KSEK (improved from -5,567 KSEK year-over-year); for nine months: -3,406 KSEK (improved from -10,973 KSEK year-over-year).

  • Equity as of September 30: 6,193 KSEK; equity/assets ratio: 36% (down from 61% year-over-year).

  • Cash and cash equivalents: 4,290 KSEK (up from 1,577 KSEK year-over-year).

Outlook and guidance

  • Focus for year-end is on achieving cash flow positivity, growing recurring revenues from treatment kits, and expanding in North America and Europe.

  • Management expects continued growth and aims to end the year on a high note.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Scandinavian ChemoTech earnings date

Logotype for Scandinavian ChemoTech
Q4 20253 Mar, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Scandinavian ChemoTech earnings date

Logotype for Scandinavian ChemoTech
Q4 20253 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Scandinavian ChemoTech is a medical technology company specializing in innovative treatment solutions for cancer and chronic pain. The company develops and markets therapies based on its patented Tumor-Specific Electroporation (TSE) technology, designed to enhance the effectiveness of chemotherapy for specific cancers. Its products are intended to provide minimally invasive and targeted treatments.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage